Compound details
3-Oxoglutaric acid
| Compound ID | CDAMM00991 |
|---|---|
| Common name | 3-Oxoglutaric acid | IUPAC name | 3-oxopentanedioic acid |
| Molecular formula | C5H6O5 |
| Retention time | 17.53 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 147.03 | Theoretical mz | 147.029 |
| Error | 2.88 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.7351 |
| Inchi key | OXTNCQMOKLOUAM-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C(O)CC(=O)CC(=O)O |
| Superclass | Organic acids and derivatives |
| Class | Keto acids and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P24046 | GABRR1 | GABA receptor rho-1 subunit | T99665 | SEA |
| O75899 | GABBR2 | GABA-B receptor | T42446 | SEA |
| P48066 | SLC6A11 | GABA transporter 3 | T38200 | SEA |
| O75899 | GABBR2 | GABA-B receptor | T42446 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SwissTargetPrediction and SEA |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SEA |
| Q9Y4C1 | KDM3A | Lysine-specific demethylase 3A | T25362 | SEA |
| O15054 | KDM6B | Lysine-specific demethylase 6B | T56057 | SEA |
| P04035 | HMGCR | HMG-CoA reductase | T53585 | SwissTargetPrediction |
| P41229 | KDM5C | Lysine-specific demethylase 5C | T85540 | SEA |
| Q9Y2K7 | KDM2A | Lysine-specific demethylase 2A | T71949 | SEA |
| Q6ZMT4 | KDM7A | Lysine-specific demethylase 7A/7B | T18784 | SEA |
| Q9UPP1 | PHF8 | Histone lysine demethylase PHF8 | T00933 | SEA |
| P28476 | GABRR2 | GABA(A) receptor rho2 | T90682 | SEA |
| Q9UN88 | GABRQ | GABA(A) receptor theta | T15161 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T42446 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O75899 | GABBR2 |
| T42446 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O75899 | GABBR2 |
| T42446 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | O75899 | GABBR2 |
| T42446 | DI0290 | Narcolepsy | [ICD-11: 7A20] | O75899 | GABBR2 |
| T38200 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P48066 | SLC6A11 |
| T42446 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O75899 | GABBR2 |
| T42446 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O75899 | GABBR2 |
| T42446 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | O75899 | GABBR2 |
| T42446 | DI0290 | Narcolepsy | [ICD-11: 7A20] | O75899 | GABBR2 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T53585 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P04035 | HMGCR |
| T53585 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P04035 | HMGCR |
| T53585 | DI0128 | Dyslipidemia | [ICD-11: 5C80-5C81] | P04035 | HMGCR |
| T53585 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P04035 | HMGCR |
| T53585 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P04035 | HMGCR |
| T53585 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P04035 | HMGCR |
| T53585 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P04035 | HMGCR |